BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20858093)

  • 1. Dasatinib is effective against optic nerve infiltration of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Satake A; Okada M; Asada T; Fujita K; Ikegame K; Tamaki H; Fujimori Y; Ogawa H
    Leuk Lymphoma; 2010 Oct; 51(10):1920-2. PubMed ID: 20858093
    [No Abstract]   [Full Text] [Related]  

  • 2. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
    Ottmann OG; Pfeifer H
    Hematology Am Soc Hematol Educ Program; 2009; ():371-81. PubMed ID: 20008223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excellent response to dasatinib of childhood Philadelphia positive intracranial acute lymphoblastic leukaemia tumours.
    Bhadri VA; Satharasinghe K; Sugo E; Barbaric D; Trahair TN
    Br J Haematol; 2011 Feb; 152(3):347-9. PubMed ID: 21155759
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological properties and clinical efficacy of dasatinib hydrate (Sprycel), an anticancer drug for chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia].
    Fujii Y; Amano M; Seriu T
    Nihon Yakurigaku Zasshi; 2009 Sep; 134(3):159-67. PubMed ID: 19749489
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolated ocular relapse in acute lymphoblastic leukemia.
    Dua T; Chandra J; Arora M; Saxena YK; Jain R; Narayan S
    Indian J Pediatr; 1999; 66(3):470-2. PubMed ID: 10798098
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of dasatinib in the patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance to imatinib and renal failure.
    Sonmez M; Cobanoglu U; Ovali E; Omay SB
    J Clin Pharm Ther; 2008 Jun; 33(3):329-30. PubMed ID: 18452422
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia.
    Millot F; Cividin M; Brizard F; Chomel JC; Méchinaud F; Guilhot F
    Pediatr Blood Cancer; 2009 Jul; 52(7):891-2. PubMed ID: 19202569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic post-transplant dasatinib administration in a pediatric patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Watanabe A; Chansu S; Ogawa A; Asami K; Imamura M
    Pediatr Int; 2013 Jun; 55(3):e56-8. PubMed ID: 23782380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential leukemic infiltration and human herpesvirus optic neuropathy in acute lymphoblastic leukemia.
    Bhatt UK; Gregory ME; Madi MS; Fraser M; Woodruff GH
    J AAPOS; 2008 Apr; 12(2):200-2. PubMed ID: 18329931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bilateral optic nerve head infiltration: Case report of relapse of acute lymphoblastic leukemia].
    Tijani M; Albaroudi N; Sibari O; Daoudi R
    J Fr Ophtalmol; 2016 Nov; 39(9):e261-e263. PubMed ID: 27751559
    [No Abstract]   [Full Text] [Related]  

  • 12. Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Teng CL; Yu JT; Chen HC; Hwang WL
    Ann Hematol; 2013 Aug; 92(8):1137-9. PubMed ID: 23307602
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute Lymphoblastic Leukemia Relapse Presenting as Optic Nerve Infiltration.
    Wong BJ; Berry JL
    JAMA Ophthalmol; 2017 Jan; 135(1):e164656. PubMed ID: 28030719
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of dasatinib in treatment of imatinib-resistant BCR/ABL positive leukemia].
    Zhu Y; Pan LQ; Qian SX; Song P; Yu H; Zhang SJ; Ge Z; Hong M; Tian T; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):581-6. PubMed ID: 23815902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukaemic infiltration of the optic nerve as the initial manifestation of leukaemic relapse.
    Lin YC; Wang AG; Yen MY; Hsu WM
    Eye (Lond); 2004 May; 18(5):546-50. PubMed ID: 15131694
    [No Abstract]   [Full Text] [Related]  

  • 16. Teaching NeuroImages: Optic and third cranial nerves infiltration as initial relapse of acute lymphoblastic leukemia.
    Shor N; Fardeau C; Bonnin S
    Neurology; 2019 Aug; 93(8):e829-e830. PubMed ID: 31427499
    [No Abstract]   [Full Text] [Related]  

  • 17. [Leukemic infiltration of the optic nerve].
    Merle H; Richer R; Donnio A; Jean-Charles A
    J Fr Ophtalmol; 2006 Nov; 29(9):e25. PubMed ID: 17114988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dasatinib (Sprycel) for CML and Ph + ALL.
    Med Lett Drugs Ther; 2007 Jan; 49(1252):6-7. PubMed ID: 17220814
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bilateral optic nerve infiltration in acute lymphoblastic leukemia in remission].
    Mateo J; Abarzuza R; Núñez E; Cristóbal JA
    Arch Soc Esp Oftalmol; 2007 Mar; 82(3):167-70. PubMed ID: 17357894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dasatinib after allogeneic stem cell transplantation in a child with Philadelphia chromosome positive acute lymphoblastic leukemia.
    de Castro CG; Gregianin LJ; Meneses CF; Brunetto AL
    Pediatr Blood Cancer; 2009 Dec; 53(6):1161. PubMed ID: 19621456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.